Feedback / Questions
nintedanib inhaled (AP02) - Avalyn Pharma
https://www.globenewswire.com/news-release/2023/03/30/2637585/0/en/Avalyn-Pharma-Reports-Results-of-Phase-1-Study-of-AP02-in-Healthy-Volunteers-and-Participants-with-Idiopathic-Pulmonary-Fibrosis.html
Mar 30, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next